Examining Common Denial Reasons for Drug Screenings
By: Dyana Williams, Client Engagement Manager, Lighthouse RCM Solutions Presumptive drug testing screens for drug presence, while definitive testing identifies specific drugs and concentrations. Both aid in patient care and treatment decisions. In the world of...
CMS to Withdraw NCCI Edit Impacting Drug Testing
CMS is withdrawing NCCI PTP edits between Column One codes 80305, 80306, and 80307 for presumptive test(s), and Column Two codes G0480 – G0483, and G0659 for definitive test(s), according to an announcement posted on the agency’s website and communications from...
Unpacking the New NCCI Billing Edit Impacting Drug Testing
On July 1, 2023, the Centers for Medicare and Medicaid Services (“CMS”) implemented a new National Correct Coding Initiative (“NCCI”) Procedure-to-Procedure (“PTP”) edit for codes 80305, 80306, and 80307 for presumptive drug test(s), and codes G0480-G0483, and...
Cuts for Labs, Pathology again proposed for 2024 Medicare Fee Schedule
The 2024 Medicare Physician Fee Schedule Proposed Rule released July 13 is already generating pushback from lab and pathology advocates, such at the College of American Pathologists (CAP), who contend these services and the physicians who provide them cannot sustain...